{"id":"https://openalex.org/W2124748060","doi":"https://doi.org/10.1158/1535-7163.mct-07-0079","title":"Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines","display_name":"Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines","publication_year":2007,"publication_date":"2007-10-01","ids":{"openalex":"https://openalex.org/W2124748060","doi":"https://doi.org/10.1158/1535-7163.mct-07-0079","mag":"2124748060","pmid":"https://pubmed.ncbi.nlm.nih.gov/17938260"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-07-0079","doi":"https://doi.org/10.1158/1535-7163.mct-07-0079","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0079","pdf_url":"https://aacrjournals.org/mct/article-pdf/6/10/2664/1874381/2664.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/6/10/2664/1874381/2664.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045254331","display_name":"David R. Emlet","orcid":"https://orcid.org/0000-0003-2131-9902","observed_orcids":["https://orcid.org/0000-0003-2131-9902"]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Emlet","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kathryn A. Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn A. Brown","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091391677","display_name":"Deborah L. Kociban","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah L. Kociban","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106083403","display_name":"Agnese A. Pollice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Agnese A. Pollice","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charles A. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles A. Smith","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007102084","display_name":"Ben Brian L. Ong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ben Brian L. Ong","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027859218","display_name":"Stanley E. Shackney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800275141","display_name":"Allegheny General Hospital","ror":"https://ror.org/02gy6qp39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I2800275141"]},{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]},{"id":"https://openalex.org/I72816309","display_name":"Drexel University","ror":"https://ror.org/04bdffz58","country_code":"US","type":"education","lineage":["https://openalex.org/I72816309"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley E. Shackney","raw_affiliation_strings":["Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cancer Cell Biology and Genetics, Department of Human Oncology, Drexel University College of Medicine and the Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I2800275141","https://openalex.org/I4210087180","https://openalex.org/I72816309"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2147,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.88123532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"6","issue":"10","first_page":"2664","last_page":"2674"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6890000104904175},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7580000162124634},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.996999979019165},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6119999885559082},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.8140000104904175},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8479999899864197},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.5559999942779541},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.8600000143051147},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6399999856948853},{"id":"https://openalex.org/keywords/drug-response","display_name":"drug response","score":0.375}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.9639108180999756},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8231946229934692},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.631654679775238},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5890294909477234},{"id":"https://openalex.org/C128240485","wikidata":"https://www.wikidata.org/wiki/Q786998","display_name":"Autocrine signalling","level":3,"score":0.5377917289733887},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5180242657661438},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49840664863586426},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.4890471398830414},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.45808589458465576},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4448942542076111},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.44363173842430115},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4343835115432739},{"id":"https://openalex.org/C2909325608","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib Hydrochloride","level":5,"score":0.4213290810585022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40547290444374084},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3733344078063965},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34012722969055176},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.308008074760437},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29127037525177},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.244631826877594},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.09040528535842896},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015151","descriptor_name":"Immunoblotting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016193","descriptor_name":"G1 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-07-0079","doi":"https://doi.org/10.1158/1535-7163.mct-07-0079","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0079","pdf_url":"https://aacrjournals.org/mct/article-pdf/6/10/2664/1874381/2664.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:17938260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17938260","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1031.2406","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1031.2406","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://mct.aacrjournals.org/content/molcanther/6/10/2664.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-07-0079","doi":"https://doi.org/10.1158/1535-7163.mct-07-0079","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-07-0079","pdf_url":"https://aacrjournals.org/mct/article-pdf/6/10/2664/1874381/2664.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2124748060.pdf","grobid_xml":"https://content.openalex.org/works/W2124748060.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1531524380","https://openalex.org/W1593316358","https://openalex.org/W1804903119","https://openalex.org/W1897472077","https://openalex.org/W1964321121","https://openalex.org/W1969328947","https://openalex.org/W1982682785","https://openalex.org/W1988535092","https://openalex.org/W1989402142","https://openalex.org/W1990624032","https://openalex.org/W2007435673","https://openalex.org/W2015878053","https://openalex.org/W2024893022","https://openalex.org/W2032037224","https://openalex.org/W2039102394","https://openalex.org/W2040972148","https://openalex.org/W2049582178","https://openalex.org/W2059340162","https://openalex.org/W2077945404","https://openalex.org/W2092565173","https://openalex.org/W2095156669","https://openalex.org/W2095893831","https://openalex.org/W2099011923","https://openalex.org/W2100506523","https://openalex.org/W2101577390","https://openalex.org/W2111580206","https://openalex.org/W2127640466","https://openalex.org/W2128402413","https://openalex.org/W2130840817","https://openalex.org/W2133138712","https://openalex.org/W2134989772","https://openalex.org/W2138727065","https://openalex.org/W2142525191","https://openalex.org/W2144503474","https://openalex.org/W2146106602","https://openalex.org/W2146384083","https://openalex.org/W2147684102","https://openalex.org/W2148346100","https://openalex.org/W2149908785","https://openalex.org/W2154100643","https://openalex.org/W2155977433","https://openalex.org/W2156084306","https://openalex.org/W2161821474","https://openalex.org/W2166573361","https://openalex.org/W2167901553","https://openalex.org/W2168482167","https://openalex.org/W2170329700","https://openalex.org/W2171275402","https://openalex.org/W2318605753"],"related_works":["https://openalex.org/W2737680693","https://openalex.org/W2001110028","https://openalex.org/W7097012505","https://openalex.org/W2326757487","https://openalex.org/W2032699899","https://openalex.org/W2156904431","https://openalex.org/W2128230789","https://openalex.org/W2146383973","https://openalex.org/W1969653304","https://openalex.org/W2015878053"],"abstract_inverted_index":{"Human":[0],"epidermal":[1,7],"growth":[2,8,55,59,120],"factor":[3,9,56,60],"receptor-2":[4],"(HER2)":[5],"and":[6,37,50,64,82,85,177,197,226,232,250],"receptor":[10],"(EGFR)":[11],"heterodimerize":[12],"to":[13,35,103,253],"activate":[14],"mitogenic":[15],"signaling":[16],"pathways.":[17],"We":[18],"have":[19],"shown":[20],"previously,":[21],"using":[22],"MCF7":[23],"subcloned":[24],"cell":[25,89,99,132,160,187],"lines":[26,133],"with":[27,44,164],"graded":[28],"levels":[29,45,105],"of":[30,46,94,106,111,119,144,155,167,208,224,229,247],"HER2":[31,47,49,107,168],"expression,":[32],"that":[33,61,70,79,141,194,221],"responsiveness":[34],"trastuzumab":[36],"AG1478":[38],"(an":[39],"anti-EGFR":[40],"agent),":[41],"varied":[42],"directly":[43],"expression.":[48,108],"EGFR":[51],"up-regulate":[52],"vascular":[53],"endothelial":[54],"(VEGF),":[57],"a":[58,92,116,203],"promotes":[62],"angiogenesis":[63],"participates":[65],"in":[66,74,86,91,101,128,147,158,185,210,239],"autocrine":[67],"growth-stimulatory":[68],"pathways":[69],"might":[71,234],"be":[72,254],"active":[73],"vitro.":[75],"Here,":[76],"we":[77],"show":[78],"trastuzumab,":[80,230],"erlotinib,":[81,231],"bevacizumab,":[83],"individually":[84],"combination,":[87],"inhibit":[88],"proliferation":[90],"panel":[93],"unrelated":[95],"human":[96],"breast":[97,241],"cancer":[98],"lines,":[100],"proportion":[102],"their":[104],"The":[109,151],"combination":[110,127,148,201],"all":[112,186],"three":[113],"drugs":[114,146],"provided":[115],"greater":[117],"suppression":[118],"than":[121],"any":[122],"single":[123],"drug":[124,200],"or":[125],"two-drug":[126],"the":[129,142,165,198,222],"high":[130],"HER2-expressing":[131],"(P":[134],"<":[135],"0.001).":[136],"Combination":[137],"index":[138],"analysis":[139],"suggested":[140],"effects":[143,223,245],"these":[145,244],"were":[149],"additive.":[150],"pretreatment":[152],"net":[153,182],"level":[154,166],"VEGF":[156,183],"production":[157,184],"each":[159,179],"line":[161],"was":[162],"correlated":[163],"expression":[169],"(r":[170],"=":[171,174],"0.883,":[172],"P":[173],"0.016).":[175],"Trastuzumab":[176],"erlotinib":[178,195],"reduced":[180],"total":[181],"lines.":[188],"Multiparameter":[189],"flow":[190],"cytometry":[191],"studies":[192,219],"indicated":[193],"alone":[196],"triple":[199],"produced":[202],"prolonged":[204],"but":[205,212],"reversible":[206],"blockade":[207],"cells":[209],"G1,":[211],"did":[213],"not":[214],"increase":[215],"apoptosis":[216],"substantially.":[217],"These":[218],"suggest":[220],"two":[225],"three-drug":[227],"combinations":[228],"bevacizumab":[233],"offer":[235],"potential":[236],"therapeutic":[237],"advantages":[238],"HER2-overexpressing":[240],"cancers,":[242],"although":[243],"are":[246,251],"low":[248],"magnitude,":[249],"likely":[252],"transient.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}